KR101897401B1 - Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component - Google Patents

Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component Download PDF

Info

Publication number
KR101897401B1
KR101897401B1 KR1020170039343A KR20170039343A KR101897401B1 KR 101897401 B1 KR101897401 B1 KR 101897401B1 KR 1020170039343 A KR1020170039343 A KR 1020170039343A KR 20170039343 A KR20170039343 A KR 20170039343A KR 101897401 B1 KR101897401 B1 KR 101897401B1
Authority
KR
South Korea
Prior art keywords
spicule
skin
cosmetic composition
powder
acid
Prior art date
Application number
KR1020170039343A
Other languages
Korean (ko)
Inventor
이재섭
한창성
Original Assignee
이재섭
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이재섭 filed Critical 이재섭
Priority to KR1020170039343A priority Critical patent/KR101897401B1/en
Application granted granted Critical
Publication of KR101897401B1 publication Critical patent/KR101897401B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition in which alpha-hydroxy acid (AHA) and beta-hydroxy acid (BHA) which are kinds of fruit acid are included in a lumen of spicule (bone pieces) which is a bone structure of sponges (Spongilla) treated with ultra-high pressure. The spicule inclusion powder of the present invention improves skin exfoliating functions as AHA and BHA included in the lumen of spicule are continuously released with the lapse of time. Since the spicule inclusion powder promotes skin cell exfoliation and has massaging effects due to scrubbing, the spicule inclusion powder can be useful as a cosmetic composition for exfoliating skin with excellent exfoliating functions.

Description

초고압처리를 이용한 스피큘 포접분말을 유효성분으로 함유하는 피부 각질박리용 화장료 조성물{Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component}Technical Field [0001] The present invention relates to a cosmetic composition for skin exfoliation comprising a spicule inclusion powder as an active ingredient,

본 발명은 초고압처리를 이용하여 해면동물(스폰질라 라쿠스트리스 (Spongilla lacustris L.))의 골 구조물인 스피큘(골편)의 내강(內腔)에 알파 히드록시 애시드(alpha-hydroxy acid, AHA) 또는 베타 히드록시 애시드(beta-hydroxy acid, BHA)를 포접시킨 화장료 조성물에 관한 것으로, 더욱 상세하게는, 20℃에서 80MPa로 5분간 초고압처리한 스피큘 분말을 -40℃에서 1일간 동결건조한 후, AHA와 BHA를 주입시켜 제조한 스피큘 포접분말을 이용한 피부 각질 박리용 화장료 조성물에 관한 것이다.The present invention relates to a method for preparing an alpha-hydroxy acid (AHA) by adding an alpha-hydroxy acid to an internal cavity of a spinal bone (bone fragment) of a sponge animal ( Spongilla lacustris L.) ) Or beta-hydroxy acid (BHA). More specifically, the present invention relates to a cosmetic composition which is prepared by lyophilizing a speical powder treated with ultrahigh pressure at 20 DEG C and 80 MPa for 5 minutes at -40 DEG C To a cosmetic composition for exfoliating skin using a spinel inclusion powder prepared by injecting AHA and BHA.

해면동물(Porifera)은 해면동물문 동물의 총칭이다. 해면동물은 간단한 구조의 후생동물로서, 근육신경계소화계배설계의 분화가 없는 하등동물로서 현재 약 1,000종 정도가 알려져 있다. 동정세포가 있어서 이것으로 입수공을 통해 들어온 먹이를 받아들이는데, 이때의 동정세포는 한 개의 편모를 가지므로 원생동물의 편모충류와 비슷하다고 여겨진다. 다른 후생동물과 구별하여 '측생동물(側生動物)'이라고도 한다. 해면동물의 구조는 다른 동물에 비해 매우 단순하지만, 주위 환경에 성공적으로 적응한 동물이다. 세계적으로 7,000종 이상이 있는 것으로 알려졌고, 대부분 바다에 살지만 강이나 호수 등 담수에 사는 것도 있다. 해면동물의 크기는 쌀알 크기부터 수 미터에 이르는 것도 있다. 바위를 얇게 덮어 싸는 모양, 덩어리 모양, 나뭇가지 모양, 관 모양 등 다양한 형태로 성장한다.Porifera is a generic name for sphenoid animals. Sponge animal is a simple structure of welfare animal, muscle nervous system digestive system without the differentiation of the lower animal is now known as about 1,000 species. It has a sympathetic cell, which accepts the food that comes in through the entry hole, which is considered to be similar to the protozoan of protozoan because it has a single flagella. It is also referred to as a "survey animal (side animal)" in distinguishing it from other welfare animals. The structure of sponges is very simple compared to other animals, but it is an animal successfully adapted to the surrounding environment. It is known that there are more than 7,000 species in the world, and most of them live in the sea but live in fresh water such as rivers and lakes. The size of sponges can range from rice grain size to several meters. It grows in a variety of forms such as a rock-covered shape, a lump shape, a twig shape, and a tubular shape.

골격은 작은 골편(骨片, spicule)이 몸을 지지하며, 석회질이나 규질로 되어 있고, 주대골편과 미소골편으로 구분된다. 그 형태는 일축(一軸, monaxon), 삼축(三軸, triaxon), 사축(四軸, tetraxon), 다축(多軸, polyaxon)형이 있으며, 골편 외에 해면질섬유(spongin fiber)를 갖고 있으며 이들은 해면동물의 동정 및 분류에 있어 매우 중요한 특징으로 이용된다. 간단한 수관계(管系, canal system)는 중앙의 위강(胃腔, spongocoel)이 대공과 많은 소공에 의해서 바깥과 통하지만 복잡한 것은 많은 편모실을 갖고 있다(Sethmann et al., Micron. 2008. Vol. 39, No. 3, 페이지 209-228).The skeleton supports the body with small fragments (bone fragments, spicules), and it is composed of calcareous or regular, and is divided into major and minor fragments. It has a spongin fiber in addition to the bone fragments. The spongin fiber is a type of spongy fiber. The shape of the spongy fiber is as follows: monaxon, triaxon, tetraxon, polyaxon, It is used as an important feature in animal identification and classification. The simple cannal system has a large number of knots in the central stomach (spongocoel), which are interconnected by the air and many pores (Sethmann et al., Micron. 2008. Vol 39, No. 3, pages 209-228).

각질해면, 관각질 해면의 부드럽고 질긴 골격은 고대부터 청소목욕칠 등에 쓰였다. 중세에는 태운 해면을 여러 질병 치료에 이용했다. 자연산 해면은 도자기보석을 만들거나 그림을 그릴 때 사용한 기록이 있으며, 최근 담수해면 동물인 스폰질라 라쿠스트리스 (Spongilla lacustris L.), 스폰질라 프라질리스 레이디(Spongilla fragilis Leidy), 및 에피다티아 플루비아틸리스(Ephydatia fluviatilis)의 골격으로부터 골격조직인 바늘 모양의 스피큘을 분리하여 화장품용 혹은 외과용 약제로서 사용되어 진다.Keratinic sponges, tubular Keratin The soft and rigid skeletons of the sponges have been used since ancient times for cleaning baths. In the Middle Ages, sponges were used to treat various diseases. The wild sponges have been used to make pottery jewelery or to draw pictures, and the recent spongy sea creatures Spongilla lacustris L.), Spongilla fragilis Leidy , and Ephydatia fluviatilis , which are skeletal tissues , are used as cosmetic or surgical agents.

스피큘은 메가스클레레스(Megascleres)와 마이크로스클레레스(Microscleres)로 두 가지로 구분되며, 메가스클레레스(Megascleres)는 60-2,000㎛의 크기로 육안으로 구분 가능하며, 마이크로스클레레스(Microscleres)는 10-60㎛의 크기로 현미경을 이용해서 관찰되어지며, 별모양, 구형, 삽모양, 표창모양, 반달모양, 바늘모양 등의 형태에 따라 아니소첼라스(Anisochelas), 첼라에(Chelae), 에우아스테르스(Euasters), 포셉(Forceps), 아이소첼라스(Isochelas), 마이크로스트롱질레스(Microstrongyles), 옥세아스(Oxeas), 스틸레(style)로 구분되며, 이 중 옥세아스(Oxeas)는 양쪽이 바늘모양이며 중심을 가로지르는 관(내강,內腔)이 발견되어 진다(Eugenio Andri et al., 2001. A proceedings of the ocean drilling program, scientific results. Vol. 180. 페이지 18).Megacleres and Microscleres are classified into Megascleres and Megascleres. The Megascleres can be classified by the naked eye with a size of 60 to 2,000 μm, and Microclerces (Microscleres) are observed with a microscope at a size of 10-60 μm and are classified into three types according to their shape, such as star shape, spherical shape, shovel shape, crescent shape, half moon shape, needle shape, (Chelae), Euasters, Forceps, Isochelas, Microstrongyles, Oxeas and Stille. Of these, (Oxeas) are found on both sides of the needle and have a tube across the center (Eugenio Andri et al., 2001. Proceedings of the Ocean Drilling Program, Vol. ).

피부는 표피, 진피, 및 피하조직으로 구성되어 있는데, 가장 바깥층인 표피의 맨 위층을 각질층이라 한다. 각질층은 신체 부위에 따라 그 두께가 다르며 손바닥과 발바닥이 가장 두껍고 눈꺼풀과 팔목 부위가 가장 얇다. 이 각질층은 표피의 기저 세포층이 끊임없이 분열하여 위로 올라오면서 생기는 것으로 피부 생성의 마지막 단계라고 할 수 있다. 정상적인 피부는 28일을 주기로 각질이 생성, 탈락되는 과정을 반복하면서 새로운 세포를 만들어낸다. 그러나 나이가 들거나 외부 요인에 의해 각질 교환주기가 길어져 탈락이 정상적으로 이루어지지 않으면 피부에 죽은 각질세포가 쌓이게 된다. 오래된 각질은 제거하지 않으면 피부 톤이 칙칙해지고 새로운 세포가 만들어지는 과정을 더디게 함으로써 전체적으로 피부 노화를 촉진하게 된다.The skin consists of epidermis, dermis, and subcutaneous tissue. The uppermost layer of the outermost epidermis is called the stratum corneum. The stratum corneum varies in thickness depending on the body part, the palms and soles are the thickest, and the eyelids and cuffs are the thinnest. This stratum corneum is the last stage of skin formation that occurs when the basal cell layer of the epidermis is constantly breaking up and coming up. Normal skin produces new cells by repeating the process of producing and removing horny cells every 28 days. However, if the age of the skin or external factors causes the keratin exchange cycle to become longer and the removal is not normally performed, dead keratinocytes accumulate on the skin. If you do not remove old keratin, your skin tone will become dull and you will slow down the process of making new cells, thereby promoting skin aging as a whole.

각질은 피부의 맨 바깥에서 유해한 이물질이 침투하는 것을 막는 장벽 역할과 유분, 수분을 보호해 주는 기능까지 한다. 따라서 과도하게 제거하면 피부가 약해지며 심할 경우 건성 습진으로 악화될 수도 있다. 이처럼 적당한 수준의 각질은 피부를 보호하게 되지만 과도한 각질은 피부 톤을 칙칙하게 만들고 수분 및 영양분의 흡수를 방해한다.The keratin also acts as a barrier to prevent ingress of harmful foreign matter from the outside of the skin, and also to protect oil and moisture. Excessive removal may weaken the skin and, in severe cases, it can be exacerbated by dry eczema. This moderate level of keratin protects the skin, but excessive keratinis makes the skin tone dull and interferes with the absorption of moisture and nutrients.

화장품에 주로 사용되는 각질제거 성분으로는 과일산의 일종인 알파 히드록시 애시드(AHA)와 버드나무 추출물에 함유돼 있는 베타 히드록시 애시드(BHA) 등이 있다. 이들 성분은 각질이 쉽게 떨어져 나가도록 함으로써 수분을 함유한 새로운 세포가 생성되는 과정을 촉진하게 된다. AHA는 가장 대표적인 화학적 각질제거성분으로, 산의 작용으로 각질층에서 각질 사이의 연결고리를 제거하는데 도움을 주고, 각질을 부드럽게 녹여주는 효과를 나타낸다. AHA에 해당하는 성분에는 글리콜산(Glycolic acid), 젖산(Lactic acid), 말산(Malic acid), 구연산(Citric acid), 주석산(Tartaric acid) 등이 있다. BHA는 AHA와 마찬가지로 대표적인 화학적 각질제거성분의 하나로, 화장품 등에서 가장 많이 볼 수 있는 BHA 성분으로는 살리실산(salicylic acid)이 있다. AHA와 다르게 BHA는 지용성이기 때문에, 여드름의 원인으로 여드름 부위에 각질이 과하게 쌓여 있는 부위를 효과적으로 제거해줌으로써, 피지분비가 많고 여드름이 잘 나는 피부에도 침투가 쉬워 여드름용 제품에도 많이 사용되고 있다. 그러나 AHA와 BHA는 저농도로 사용할 경우 피부정돈 및 각질 제거 효능을 가져오지만, 고농도로 사용할 경우에는 피부에 강한 자극을 주어 따끔거림과 동시에 햇빛에 민감해지는 등의 부작용을 가져 오게 된다(Kornhauser et al., Clin Cosmet Investig Dermatol. 2010. Vol. 24, No. 3, 페이지 135-142). Exfoliants, which are mainly used in cosmetics, include alpha hydroxy acid (AHA), a kind of fruit acid, and beta hydroxy acid (BHA), contained in willow extract. These ingredients allow the keratin to fall off easily, thus promoting the process of producing new cells containing water. AHA is the most typical chemical exfoliating ingredient, which helps remove the connective ring between the keratin layers in the stratum corneum through the action of acid, and shows the effect of gently dissolving keratin. Glycolic acid, Lactic acid, Malic acid, Citric acid, Tartaric acid and the like are the components corresponding to AHA. BHA is one of the representative chemical exfoliating ingredients as well as AHA. Salicylic acid is the most common BHA ingredient in cosmetics. Unlike AHA, BHA is liposoluble, so it effectively removes the area where acne is overly accumulated as a cause of acne, so it is easy to penetrate even skin that has sebum secretion and acne. However, AHA and BHA have the side effects of skin care and exfoliation efficacy when used at low concentration, but they have strong side effects when they are used at high concentration, such as being tingling and being sensitive to sunlight (Kornhauser et al. , Clin Cosmet Investig Dermatol. 2010. Vol. 24, No. 3, pages 135-142).

이와 관련하여 해면에서 얻은 천연 바이오스폰지로부터 효능 물질 전달률이 높은 미세침을 정제 및 추출하는 방법(한국공개특허 제2015-0116620호), 인체지방줄기세포 배양액과 상피세포성장인자(EGF), 혈관내피성장인자(VEGF), 인슐린유사 성장인자(IGF-1), 아세틸헥사펩타이드-8, 카퍼트리펩타이드-1(Copper tripeptide-1), 식물 추출물 발효액 등을 스피큘과 혼합하여 제조한 피부관리용 화장품 조성물 및 이의 제조방법(한국등록특허 제10-1678621호)에 대한 연구가 알려져 있으나, 종래의 기술들은 AHA나 BHA 같은 각질 제거 성분들이 짧은 시간 내에 과량으로 방출되어 피부 자극을 유발시키는 문제점이 있으며, 최근에는 피부 자극을 감소시키면서 피부 각질 박리효과를 가진 화장료 조성물에 대한 필요성이 대두되고 있다.In connection with this, a method of purifying and extracting micro-needles having a high efficacy ratio from a natural bio-sponge obtained from the sea surface (Korean Laid-open Patent Application No. 2015-0116620), human adipose stem cell culture medium and epithelial growth factor (EGF) Cosmetics for skin care, prepared by mixing VEGF, insulin-like growth factor (IGF-1), acetylhexapeptide-8, copper tripeptide-1 and plant extract fermentation broth with spicule (Korean Patent No. 10-1678621). However, the conventional techniques have a problem that the exfoliation components such as AHA and BHA are excessively released within a short time, causing skin irritation, In recent years, a need has arisen for a cosmetic composition having skin peeling effect while reducing skin irritation.

본 발명은 상기한 종래의 문제점을 해결하기 위한 것으로, 본 발명에서는 초고압처리를 이용하여 해면동물(Spongilla lacustris L.)의 골 구조물인 스피큘의 내강(內腔)에 AHA (alpha-hydroxy acid)와 BHA (beta-hydroxy acid)를 포접시켜 사용함으로써 피부도포 후 시간이 경과함에 따라 AHA나 BHA을 지속적으로 방출되게 하고, 이로써 과량의 성분이 피부에 도포되는 것을 막아주는 것과 동시에 스피큘 분말의 마사지에 의한 피부 박리효과를 제공하여 각질제거 효능이 월등히 향상된 것을 확인함으로써, 본 발명을 완성하였다.SUMMARY OF THE INVENTION The present invention has been made to solve the above-mentioned problems of the prior art, and it is an object of the present invention to provide an AHA (alpha-hydroxy acid) in the lumen of a speckle, which is a bone structure of a sponge animal ( Spongilla lacustris L.) And BHA (beta-hydroxy acid) are enclosed and used so that AHA and BHA are continuously released as time passes after application of the skin, thereby preventing excessive ingredients from being applied to the skin, and at the same time, The present invention has been accomplished by confirming that the exfoliation efficacy is greatly improved.

상기 목적을 달성하기 위하여, 본 발명은 초고압처리한 피부 각질 제거 성분을 스피큘 내강(內腔)에 포접시킨 스피큘포접분말을 유효성분으로 함유하는 피부 각질 박리용 화장료 조성물을 제공한다.In order to accomplish the above object, the present invention provides a cosmetic composition for exfoliating the skin comprising, as an active ingredient, a spinel inclusion powder in which a skin exfoliating component treated with ultrahigh pressure is enclosed in a spinal lumen.

본 발명에 따른 초고압처리한 피부 각질 제거 성분을 스피큘 내강(內腔)에 포접시킨 스피큘포접분말을 유효성분으로 함유하는 피부 각질 박리용 화장료 조성물은 초고압을 이용한 스피큘의 내강(內腔)에 AHA나 BHA 주입 후 동결 건조를 수행함으로써 내강 내 유효성분들을 고착시켜 건조과정에서 유액과 함께 밖으로 유출되는 것을 방지하여 AHA나 BHA를 보다 효과적으로 스피큘에 포접할 수 있어, 피부 도포 시 적정량의 AHA나 BHA가 지속적으로 방출되어 피부각질의 턴오버를 촉진함으로써 효과적으로 피부각질을 제거할 수 있다. 따라서 상기 조성물은 피부 각질 박리용 화장료 조성물로 유용하게 사용될 수 있다.The cosmetic composition for exfoliating the skin comprising the speckle inclusion powder in which the skin exfoliation component treated with ultrahigh pressure according to the present invention is encapsulated in the inner lumen of the spine as an active ingredient, , AHA or BHA is lyophilized to fix the active ingredients in the lumen, thereby preventing the AHA or BHA from leaking out along with the liquid during the drying process. Thus, AHA or BHA can be effectively applied to the speckle, And BHA are continuously released to promote turnover of the skin horny, thereby effectively removing the horny skin. Therefore, the composition can be effectively used as a cosmetic composition for exfoliating skin.

상기 목적을 달성하기 위하여, 본 발명은 초고압처리한 피부 각질 제거 성분을 스피큘 내강(內腔)에 포접시킨 스피큘포접분말을 유효성분으로 함유하는 피부 각질 박리용 화장료 조성물을 제공한다. In order to accomplish the above object, the present invention provides a cosmetic composition for exfoliating the skin comprising, as an active ingredient, a spinel inclusion powder in which a skin exfoliating component treated with ultrahigh pressure is enclosed in a spinal lumen.

상기 초고압처리 시 온도는 바람직하게는 10℃ 내지 60℃이고, 더욱 바람직하게는 10℃ 내지 40℃이나, 이에 제한되지 않는다.The temperature at the ultra-high pressure treatment is preferably 10 to 60 DEG C, more preferably 10 to 40 DEG C, but is not limited thereto.

상기 초고압처리 시 압력은 바람직하게는 10MPa내지 100MPa이고, 더욱 바람직하게는 50MPa 내지 100MPa이고, 더욱더 바람직하게는 70MPa 내지 90MPa이나, 이에 제한되지 않는다.The pressure during the ultrahigh-pressure treatment is preferably 10 MPa to 100 MPa, more preferably 50 MPa to 100 MPa, and still more preferably 70 MPa to 90 MPa.

상기 초고압처리 시 시간은 바람직하게는 5~10분이나, 이에 제한되지 않는다.The time for the ultrahigh pressure treatment is preferably 5 to 10 minutes, but is not limited thereto.

상기 피부 각질 제거 성분은 글리콜산(Glycolic acid), 젖산(Lactic Acid), 말산(Malic Acid), 구연산(Citric Acid) 등과 같은 알파 히드록시 애시드(alpha-hydroxy acid, AHA) 또는 살리실산(salicylic acid) 등과 같은 베타 히드록시 애시드(beta-hydroxy acid, BHA)일 수 있으나, 이에 제한되지 않는다.The skin exfoliating component may be selected from the group consisting of alpha-hydroxy acid (AHA) or salicylic acid such as glycollic acid, lactic acid, malic acid, citric acid, But are not limited to, beta-hydroxy acid (BHA) such as < RTI ID = 0.0 >

상기 스피큘은 해면동물로부터 유래된 것을 특징으로 하며, 해면동물은 스폰질라 라쿠스트리스(Spongilla lacustris L.), 스폰질라 프라질리스 레이디(Spongilla fragilis Leidy), 및 에피다티아 플루비아틸리스(Ephydatia fluviatilis) 중 어느 하나일 수 있으나, 이에 제한되지 않는다.The speckle is characterized as originating from a spongy animal, wherein the spongy animal is selected from the group consisting of Spongilla lacustris L., Spongilla fragilis Leidy, and Ephydatia spp. fluviatilis . < / RTI >

상기 스피큘 포접 분말은 건식건조, 습식건조, 동결건조 등을 통해 제조될 수 있고, 바람직하게는 동결건조를 통해 제조될 수 있으나, 이에 제한되지 않는다.The spinel inclusion powder can be prepared through dry drying, wet drying, freeze drying and the like, preferably, but not exclusively, by lyophilization.

또한, 상기 스피큘 포접분말은 화장료 조성물 총 중량 대비 건조 중량으로 0.01% 내지 10% 함량이거나, 더 바람직하게는 0.05% 내지 8% 함량이거나, 더욱더 바람직하게는 0.1% 내지 5% 함량으로 포함될 수 있으나, 이에 제한되지 않는다.The content of the spinel inclusion powder may be 0.01% to 10%, more preferably 0.05% to 8%, or even more preferably 0.1% to 5% by dry weight based on the total weight of the cosmetic composition , But is not limited thereto.

또한, 상기 화장료는 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스 또는 팩 등의 제형일 수 있으나, 이에 제한되지 않는다.The cosmetics may be formulations such as lotion, skin, lotion, nutritional lotion, nutritional cream, massage cream, essence or pack, but are not limited thereto.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited thereto.

실시예Example 1:  One: 스피큘Spicular 포접분말Graft powder 제조 Produce

1) 글리콜산(Glycolic acid)용액 제조1) Preparation of Glycolic acid solution

98% 글리콜산(Glycolic acid, Sigma 사, G8284) 10g을 5.0 중량%로 함유되도록 정제수와 에탄올 혼합액(20 중량%) 50g에 첨가하여, 40℃에서 1시간 교반하여 완전히 용해한 후, 와트만(Whatman) #5 여과지로 여과하여 글리콜산 5.0 중량% 용해액을 제조하였다. 10 g of 98% glycolic acid (Sigma, G8284) was added to 50 g of a mixture of purified water and ethanol (20% by weight) so as to contain 5.0% by weight and stirred at 40 캜 for 1 hour to completely dissolve. ) # 5 filter paper to prepare a 5.0 wt% solution of glycolic acid.

2) 스피큘혼합액제조2) Manufacture of spike mixture

스폰질라 라쿠스트리스 엘(Spongilla lacustris L.)로부터 정제한 정제 스피큘(코사인 사) 10g을 상기 1)에서 제조한 글리콜산 5.0 중량% 용해액 20g에 혼합하여 10분간 40℃에서 교반시켰다.10 g of purified spirulina (cosine) purified from Spongilla lacustris L. was mixed with 20 g of the 5.0 wt% solution of glycolic acid prepared in 1) and stirred at 40 캜 for 10 minutes.

3) 초고압처리3) Ultra high pressure treatment

비닐 팩에 상기 2)에서 제조한 제조혼합액 30g을 넣어 진공 감압한 후, 초고압처리기(TOYO KOATSH 사, TFS-10)를 이용하여 20℃에서 80MPa로 5분 가압처리 하였으며 이를 5회 반복하였다. 30 g of the preparation mixture prepared in the above 2) was added to the plastic pack, and the mixture was vacuum-depressurized and pressurized at 20 DEG C and 80 MPa for 5 minutes using an ultra high pressure processor (TOYO KOATSH, TFS-10).

4) 스피큘 분리 및 세척4) Spike separation and washing

초고압 처리된 3)의 제조혼합액을 와트만(Whatman) #5 여과지로 여과하여 여액을 분리하고, 여과지에 남겨진 스피큘 분말을 20 중량% 에탄올수용액 200g으로 3회 반복 세척하였다. The preparation mixture 3) was subjected to filtration through a Whatman # 5 filter paper to separate the filtrate. The speckle powder remaining on the filter paper was washed three times with 200 g of an aqueous 20 wt% ethanol solution.

5) 동결건조를 이용한 분말화5) Powdering by freeze-drying

동결건조기(일신랩, PVTFD-10R)을 이용하여 -40℃에서 1일간 동결건조하여 스피큘포접분말을 얻었다.  And lyophilized at -40 ° C for 1 day using a freeze dryer (ILSINLAP, PVTFD-10R) to obtain a spinel inclusion powder.

실시예Example 2∼5: 알파 히드록시  2 to 5: alpha hydroxy 애시드(AHA)와Acid (AHA) and 베타 히드록시  Beta hydroxy 애시드(BHA)이Acid (BHA) 포접된Enclosed 분말 제조 Powder manufacturing

상기 실시예 1과 동일한 방법으로 하기 표 1에 나타난 바와 같이, AHA와 BHA를 스피큘 내강(內腔)에 포접시켜 AHA와 BHA가 포접된 스피큘 포접분말을 제조하였다.In the same manner as in Example 1, AHA and BHA were encapsulated in a spiral lumen as shown in Table 1 below to prepare a spinel inclusion powder encapsulating AHA and BHA.

내용물contents 사용량(g)Usage (g) 용해액
(중량%, 에탄올수용액)
Solution
(Wt%, aqueous solution of ethanol)
사용량(g)Usage (g)
실시예 2Example 2 젖산(Lactic Acid)Lactic Acid 1010 2020 5050 실시예 3Example 3 말릭산(Malic Acid)Malic Acid 1010 2020 5050 실시예 4Example 4 구연산(Citric Acid)Citric Acid 1010 2020 5050 실시예 5Example 5 살리실산(sallicylic acid)Sallicylic acid 22 6060 5050

실시예 6~8: 초고압추출기의 압력을 달리한 알파 히드록시 애시드(AHA)와 베타 히드록시 애시드(BHA)가 포접된 분말 제조Examples 6 to 8: Preparation of powder encapsulating alpha hydroxy acid (AHA) and beta hydroxyacid (BHA) with different pressure of ultra-high pressure extractor

상기 실시예 1의 3)의 압력을 하기 표 2에 나타낸 바와 같이 달리하여, 실시예 1의 1), 2), 4), 5) 방법으로 실험을 진행하여, AHA와 BHA를 스피큘 내강(內腔)에 포접시켜 AHA와 BHA가 포접된 스피큘 포접분말을 제조하였다.Experiments were carried out by the methods 1), 2), 4) and 5) of Example 1, except that the pressure of 3) of Example 1 was changed as shown in Table 2 below, To obtain a spinel inclusion powder encapsulating AHA and BHA.

내용물contents 처리압(MPa)Process pressure (MPa) 사용량(g)Usage (g) 용해액
(중량%,에탄올수용액)
Solution
(Wt%, aqueous solution of ethanol)
사용량(g)Usage (g)
실시예 6Example 6 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
1010 1010 2020 5050
실시예 7Example 7 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
3030 1010 2020 5050
실시예 8Example 8 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
5050 1010 2020 5050
실시예 9Example 9 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
100100 1010 2020 5050

비교예Comparative Example 1~5: 초고압  1 to 5: Ultra high pressure 비처리Untreated 포접Enclosure 분말 제조 Powder manufacturing

상기 실시예 1에서 초고압 처리를 하지 않고, 상기 실시예 1의 1), 2), 4), 5)의 제조과정을 통해 스피큘 포접분말을 제조하였고, 이를 하기 표 3에 나타내었다.The spike inclusion powder was prepared by following the procedure of 1), 2), 4), and 5) of Example 1 without performing the ultrahigh pressure treatment in Example 1, and the results are shown in Table 3 below.

내용물contents 사용량(g)Usage (g) 용해액
(중량% 에탄올수용액)
Solution
(Weight% aqueous ethanol solution)
사용량(g)Usage (g)
비교예 1Comparative Example 1 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
1010 2020 5050
비교예 2Comparative Example 2 젖산(Lactic Acid)Lactic Acid 1010 2020 5050 비교예 3Comparative Example 3 말릭산(Malic Acid)Malic Acid 1010 2020 5050 비교예 4Comparative Example 4 구연산(Citric Acid)Citric Acid 1010 2020 5050 비교예 5Comparative Example 5 살리실산(sallicylic acid)Sallicylic acid 22 6060 5050

비교예Comparative Example 6~7:  6 to 7: 동결건조 비처리Freeze-dried untreated 포접Enclosure 분말 제조 Powder manufacturing

상기 실시예 1에서 동결건조 처리를 하지 않고, 감압농축기(Rotavator R205, BUCHI사,독일)를 이용하여 65℃에서 감압 건조하여 비교예 6, 열풍건조기(SANYO 사, 일본)를 이용하여 75℃에서 건조하여 비교예 7을 상기 실시예 1의 1), 2), 3), 4)의 제조과정을 통해 스피큘 포접분말을 제조하였고, 이를 하기 표 4에 나타내었다.Dried at 65 ° C using a vacuum concentrator (Rotavator R205, BUCHI, Germany) without the lyophilization treatment in Example 1, and dried at 75 ° C using a hot air drier (SANYO, Japan) Dried to prepare a spinel inclusion powder according to the process of 1), 2), 3), and 4) of Example 1, which is shown in Table 4 below.

내용물contents 건조방식Drying method 사용량(g)Usage (g) 용해액
(중량%에탄올수용액)
Solution
(Weight% aqueous ethanol solution)
사용량(g)Usage (g)
비교예 6Comparative Example 6 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
감압건조(65℃)Drying under reduced pressure (65 ° C) 1010 2020 5050
비교예 7Comparative Example 7 글리콜산
(Glycolic acid)
Glycolic acid
(Glycolic acid)
열풍건조(75℃)Hot air drying (75 ℃) 1010 2020 5050

실험예Experimental Example 1: AHA와  1: with AHA BHA가BHA 포접된Enclosed 스피큘Spicular 포접Enclosure 분말의 pH 변화 측정 Measurement of pH change of powder

스피큘 내에 알파 히드록시 애시드(AHA)와 베타 히드록시 애시드(BAH)의 포접된 것을 확인하기 위한 각각의 시료(실시예 1~9, 비교예 1~7) 2g을 정제수 1L에 첨가하여, 상온에서 교반하여 시간에 따른 pH 변화를 측정하였으며, 그 결과는 하기 표 5에 나타난 바와 같다.2 g of each sample (Examples 1 to 9 and Comparative Examples 1 to 7) to confirm that the alpha hydroxy acid (AHA) and the beta hydroxy acid (BAH) were enclosed in the speckle were added to 1 L of purified water, And the pH change with time was measured. The results are shown in Table 5 below.

측정시간에 따른 용액의 pH 변화PH change of solution according to measuring time 시료sample 0분0 minutes 2분2 minutes 4분4 minutes 8분8 minutes 10분10 minutes 20분20 minutes 실시예 1Example 1 6.756.75 5.85.8 4.924.92 4.024.02 3.43.4 3.143.14 실시예 2Example 2 6.756.75 5.775.77 5.25.2 4.944.94 3.423.42 3.183.18 실시예 3Example 3 6.756.75 5.955.95 5.135.13 4.624.62 3.213.21 2.732.73 실시예 4Example 4 6.756.75 5.525.52 4.654.65 4.324.32 3.183.18 2.572.57 실시예 5Example 5 6.756.75 5.425.42 4.54.5 3.943.94 3.043.04 2.42.4 실시예 6Example 6 6.646.64 6.026.02 5.485.48 5.335.33 5.255.25 4.774.77 실시예 7Example 7 6.646.64 5.95.9 5.35.3 4.944.94 4.764.76 4.414.41 실시예 8Example 8 6.646.64 5.745.74 5.025.02 4.134.13 3.623.62 3.423.42 실시예 9Example 9 6.646.64 5.765.76 4.994.99 4.134.13 3.423.42 3.13.1 비교예 1Comparative Example 1 6.756.75 6.026.02 5.85.8 5.785.78 5.725.72 5.785.78 비교예 2Comparative Example 2 6.756.75 6.186.18 5.785.78 5.835.83 5.795.79 5.825.82 비교예 3Comparative Example 3 6.756.75 6.036.03 5.545.54 5.425.42 5.345.34 5.325.32 비교예 4Comparative Example 4 6.756.75 66 5.745.74 5.625.62 5.485.48 5.465.46 비교예 5Comparative Example 5 6.756.75 6.116.11 5.145.14 5.055.05 4.924.92 4.884.88 비교예 6Comparative Example 6 6.646.64 4.114.11 3.253.25 3.183.18 3.193.19 3.193.19 비교예 7Comparative Example 7 6.646.64 4.374.37 3.53.5 3.083.08 3.093.09 3.093.09

상기 표 5의 결과로부터 초고압처리공정을 적용하지 않은 시료(비교예 1~5)는 2~4분 후 pH가 일정한 값을 나타내는 것에 비하여, 초고압처리공정을 적용한 시료들은 10분이 경과하여도 지속적으로 낮아지는 현상을 확인할 수 있었다. 이는 스피큘 내부에 함유된 AHA와 BHA가 지속적으로 방출되고 있다는 것을 의미한다. 또한, 상기 결과로부터 AHA와 BHA 성분을 초고압처리 공정으로 스피큘의 내강(內腔)에 포접 시킬 수 있다는 것을 확인할 수 있었다. 또한, 실시예 1, 실시예 6~9를 통하여 초고압 처리시 압력이 50MPa이상(실시예 1, 8, 9)에서 포접이 가장 우수한 것을 확인하였고, 건조 방식을 달리한 비교예 6, 비교예 7은 포접 후 건조 과정에서 내강에 함유된 성분이 밖으로 유출되는 것을 확인할 수 있었다.From the results shown in Table 5, the pH of the samples not subjected to the ultrahigh-pressure treatment (Comparative Examples 1 to 5) was constant after 2 to 4 minutes, while the samples subjected to the ultra-high pressure treatment were continuously It is possible to confirm the phenomenon of lowering. This means that the AHA and BHA contained in the speckle are continuously released. From the above results, it was confirmed that the AHA and BHA components can be encapsulated in the lumen of the spicule by an ultra-high pressure treatment process. Further, it was confirmed through Example 1 and Examples 6 to 9 that the super-high-pressure treatment had the most excellent coverage at a pressure of 50 MPa or higher (Examples 1, 8 and 9), and Comparative Examples 6 and 7 It was confirmed that the components contained in the lumen were leaked out during the drying process after the encapsulation.

제조예Manufacturing example 1:  One: 스피큘Spicular 포접Enclosure 분말을 함유한 크림 제조 Manufacture of cream containing powder

스피큘 포접 분말을 함유한 크림의 처방예는 하기 표 6과 같다. 스피큘포접분말 제형예 1은 상기 실시예 5에 해당하는 것이고, 비교제형예 1은 비교예 5에 해당하는 것이다.The prescription examples of the cream containing the spinel inclusion powder are shown in Table 6 below. The spinel inclusion powder Formulation Example 1 corresponds to Example 5 above, and Comparative Formulation Example 1 corresponds to Comparative Example 5.

제형예 1은 카르복시 비닐폴리머와 글리세린, 부틸렌글리콜, 프로필렌글리콜, 방부제, 및 정제수를 혼합교반하면서, 80∼85℃ 사이로 가열하여 제조부에 투입한 후 유화기를 작용시킨 후, 밀납과 폴리솔베이트 60, 솔비탄세스퀴올레이트, 유동파라핀, 스쿠알란, 살리실산, 및 트리에탄올아민을 80∼85℃ 사이로 가열하여 투입한 뒤 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서, 50℃까지 냉각한 뒤 색소를 투입하고 45℃까지 냉각한 뒤 향료를 투입하고 35℃까지 냉각시킨 후 스피큘 포접 분말(실시예 5)을 투입한다. 마지막으로 25℃까지 냉각한 뒤 숙성시켜 제형예 1을 제조하였다.Formulation Example 1 was conducted by heating a mixture of a carboxyvinyl polymer, glycerin, butylene glycol, propylene glycol, an antiseptic, and purified water with stirring at 80 to 85 DEG C, 60, sorbitan sesquioleate, liquid paraffin, squalane, salicylic acid, and triethanolamine are heated to 80 to 85 DEG C and emulsified. When the emulsification is completed, the mixture is cooled to 50 ° C with stirring using an agitator, and the colorant is added. After cooling to 45 ° C, the perfume is added, cooled to 35 ° C, and then the spinel inclusion powder (Example 5) is added. Finally, the mixture was cooled to 25 DEG C and then aged to prepare Formulation Example 1.

비교제형예 1은 카르복시 비닐폴리머와 글리세린, 부틸렌글리콜, 프로필렌글리콜, 방부제, 및 정제수를 혼합교반하면서 80∼85℃로 가열하여 제조부에 투입한 후 유화기를 작용시킨 후, 밀납과 폴리솔베이트 60, 솔비탄세스퀴올레이트, 유동파라핀, 스쿠알란, 및 살리실산을 80∼85℃로 가열하여 투입한 뒤 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 50℃까지 냉각한 뒤 색소를 투입하고 45℃까지 냉각한 뒤 향료를 투입하고 35℃까지 냉각되면 스피큘분말(비교예 5)을 투입한다. 25℃까지 냉각한 뒤 숙성시켜 비교제형예 1을 제조하였다.Comparative Formulation Example 1 was carried out by heating a carboxyvinyl polymer, glycerin, butylene glycol, propylene glycol, an antiseptic, and purified water at 80 to 85 캜 while mixing and stirring, 60, sorbitan sesquioleate, liquid paraffin, squalane, and salicylic acid are heated to 80 to 85 캜 and then emulsified. After the emulsification is completed, the mixture is cooled to 50 ° C with stirring using an agitator, and the colorant is added. After cooling to 45 ° C, the perfume is added. When the mixture is cooled to 35 ° C, the spectral powder (Comparative Example 5) is added. After cooling to 25 占 폚, the comparative formulation example 1 was prepared by aging.

번호number 원료Raw material 제형예 1Formulation Example 1 비교제형예 1Comparative Formulation Example 1 대조구Control 1One 스피큘포접분말(실시예5)The spinel inclusion powder (Example 5) 22 -- -- 22 스피큘분말(비교예5)Spicule powder (Comparative Example 5) -- 22 -- 33 밀납Wax 10.010.0 10.010.0 10.010.0 44 폴리솔베이트 60Polysorbate 60 1.51.5 1.51.5 1.51.5 55 솔비탄세스퀴올레이트 Sorbitan sesquioleate 0.80.8 0.80.8 0.80.8 66 유동파라핀Liquid paraffin 40.040.0 40.040.0 40.040.0 77 스쿠알란Squalane 5.05.0 5.05.0 5.05.0 88 살리실산Salicylic acid 0.50.5 0.50.5 0.50.5 99 카르복시 비닐폴리머Carboxyvinyl polymer 0.20.2 0.20.2 0.20.2 1010 글리세린glycerin 5.05.0 5.05.0 5.05.0 1111 부틸렌글리콜Butylene glycol 3.03.0 3.03.0 3.03.0 1212 프로필렌글리콜Propylene glycol 3.03.0 3.03.0 3.03.0 1313 트리에탄올아민Triethanolamine 0.20.2 0.20.2 0.20.2 1414 방부제antiseptic 미량a very small amount 미량a very small amount 미량a very small amount 1515 색소Pigment 미량a very small amount 미량a very small amount 미량a very small amount 1616 향수perfume 미량a very small amount 미량a very small amount 미량a very small amount 1717 정제수Purified water 잔량Balance 잔량Balance 잔량Balance

실험예Experimental Example 2: 피부각질 턴오버 촉진효과 분석 2: Analysis of accelerated skin keratin turnover

스피큘 포접 분말에 의한 피부각질 턴오버 촉진효과 정도를 알아보기 위해 상기 제형예 1, 비교제형예 1과 이들이 함유되지 않은 대조구에 대하여 20~40세의 건강한 남녀 15명을 대상으로 각질 박리 효과를 측정하였다.In order to investigate the effect of promoting the skin keratin turnover by the spinel inclusion powder, 15 healthy men and women aged 20 to 40 years with respect to Formulation Example 1, Comparative Formulation Example 1, Respectively.

시료도포 전 피시험자의 팔 안쪽색상을 크로마미터(Minolta사, CR300)로 측정한 후, 10% 중량 농도의 디하이드록시 아세톤(DHA)을 힐탑챔버(The Hill Top 사)에 0.4㎖ 넣고 팔 상박부 안쪽에 6시간 동안 부착하였다. 24시간 경과 후 DHA에 의해 갈색으로 착색된 부위의 색상을 측정하여 시료 도포 전과 후의 색상차이를 측정하였다. 이후 1일 2회씩 제형예 1, 비교제형예 1, 대조군을 도포하면서 매일 탈색되는 정도를 크로마미터로 측정하여 원래의 피부색으로 돌아오는데 걸리는 시간을 측정하였다. 각질 박리율은 하기 수학식 1로 계산하였다. The color of the inside of the arm of the subject was measured with a chromometer (Minolta Co., CR300) before the application of the sample, 0.4 ml of dihydroxyacetone (DHA) with a 10% weight concentration was placed in a hilltop chamber (The Hill Top Co.) For 6 hours. After 24 hours, the color of the brown colored area was measured by DHA, and the color difference before and after the application of the sample was measured. Then, the degree of discoloration on each day was measured with a chromometer while applying Formulation Example 1, Comparative Formulation Example 1, and control group twice a day, and the time taken to return to the original skin color was measured. The exfoliation rate of keratin was calculated by the following formula (1).

[수학식 1][Equation 1]

Figure 112017030471940-pat00001
Figure 112017030471940-pat00001

Blank Turnover Time: 시료 무처리군의 각질층이 새로운 각질층으로 대체되는데 걸리는 시간.Blank Turnover Time: The time it takes to replace the stratum corneum of a sample-untreated group with a new stratum corneum.

Test Turnover Time: 시료 처리군의 각질층이 새로운 각질층으로 대체되는데 걸리는 시간.Test Turnover Time: The time it takes for the stratum corneum of the sample treatment group to be replaced with a new stratum corneum.

스피큘 포접 분말에 의한 피부각질 턴오버 촉진효과 분석 결과, 하기 표 7에 나타난 바와 같이, 비교제형예 1의 새로운 각질층으로 대체되는 시간(피부각질 턴오버에 걸리는 시간)은 15.2일, 대조군의 경우는 16.0일로 측정됐지만, 포접스피큘분말을 함유한 제형예 1은 13.5일로 측정되어, 스피큘 포접 분말에 의해 새로운 각질층으로 대체되는 시간이 현저하게 짧아진 것을 확인할 수 있었고, 각질 박리율은 포접스피큘분말을 함유한 제형예 1이 29.0%로, 비교제형예 1의 20.0%, 대조군의 15.8%에 비해 우수한 각질 박리 효과를 나타내는 것을 확인할 수 있었다.As shown in the following Table 7, the time to replace with the new stratum corneum of Comparative Formulation Example 1 (time required for skin horn turnover) was 15.2 days, and in the case of the control group Was measured to be 16.0 days. Formulation Example 1 containing the inclusion spicule powder was measured to be 13.5 days, and it was confirmed that the time for replacement with a new stratum corneum by the spicule inclusion powder was remarkably shortened, and the exfoliation rate of keratin The results are shown in Table 1. The results are shown in Table 1. The results are shown in Table 1.

시료 종류Sample type Turn over time (days)Turn over time (days) 각질 박리율(%)Percolation rate (%) 무처리군Untreated group 19.019.0 -- 제형예 1Formulation Example 1 13.513.5 29.029.0 비교 제형예 1Comparative Formulation Example 1 15.215.2 20.020.0 대조군Control group 16.016.0 15.815.8

Claims (7)

살리실산과 스피큘의 혼합물을 10~40℃, 10~100MPa의 압력에서 5∼10분 동안 초고압 처리하여 살리실산을 스피큘 내강(內腔)에 포접시킨 스피큘 포접 분말을 유효성분으로 함유하는 피부 각질 박리용 화장료 조성물.A mixture of salicylic acid and spicule is subjected to ultrahigh pressure treatment at a temperature of 10 to 40 DEG C and a pressure of 10 to 100 MPa for 5 to 10 minutes to form a spicule inclusion powder in which salicylic acid is encapsulated in a spinal luminal cavity, A cosmetic composition for peeling. 삭제delete 삭제delete 제1항에 있어서, 상기 스피큘은 해면동물로부터 얻어진 것을 특징으로 하는 피부 각질 박리용 화장료 조성물.The cosmetic composition according to claim 1, wherein the spicule is obtained from a sponge animal. 제4항에 있어서, 상기 해면동물은 스폰질라 라쿠스트리스 엘(Spongilla lacustris L.), 스폰질라 프라질리스 레이디(Spongilla fragilis Leidy), 및 에피다티아 플루비아틸리스(Ephydatia fluviatilis) 중 어느 하나인 것을 특징으로 하는 피부 각질 박리용 화장료 조성물.5. The method according to claim 4, wherein the spongy animal is a Spongilla lacustris L.), Spongilla fragile Leidy , and Ephydatia < RTI ID = 0.0 > The present invention relates to a cosmetic composition for delamination of the skin. 제1항에 있어서, 상기 스피큘 포접 분말은 -5℃ 내지 -80℃에서 동결건조 과정을 거쳐 수득된 것을 특징으로 하는 피부 각질 박리용 화장료 조성물.The cosmetic composition according to claim 1, wherein the spinel inclusion powder is obtained through lyophilization at -5 ° C to -80 ° C. 제1항에 있어서, 상기 스피큘 포접 분말은 조성물 총중량 대비 0.1% 내지 5%로 함유되는 것을 특징으로 하는 피부 각질 박리용 화장료 조성물.The cosmetic composition according to claim 1, wherein the spinel inclusion powder is contained at 0.1% to 5% of the total weight of the composition.
KR1020170039343A 2017-03-28 2017-03-28 Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component KR101897401B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020170039343A KR101897401B1 (en) 2017-03-28 2017-03-28 Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170039343A KR101897401B1 (en) 2017-03-28 2017-03-28 Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component

Publications (1)

Publication Number Publication Date
KR101897401B1 true KR101897401B1 (en) 2018-09-11

Family

ID=63596452

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170039343A KR101897401B1 (en) 2017-03-28 2017-03-28 Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component

Country Status (1)

Country Link
KR (1) KR101897401B1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200073327A (en) * 2018-12-13 2020-06-24 (주)파이온텍 Method for impregnating micropore of spicule with liposome
KR102209847B1 (en) 2020-11-06 2021-03-24 주식회사 본에스티스 Functional cosmetic composition for skin moisturizing and soothing
KR102248733B1 (en) 2020-11-06 2021-05-07 주식회사 본에스티스 Functional cosmetic composition for improving skin wrinkles and elasticity
KR102297063B1 (en) 2020-10-20 2021-09-02 박경래 Cosmetic complex composition that helps skin keratin turnover cycle, skin trouble improvement and acne symptom relief, and its manufacturing method
KR102333146B1 (en) 2021-06-14 2021-12-01 한도숙 Cosmetic composition for improving skin brightness containing spicule and method for preparing same
KR102333145B1 (en) 2021-06-14 2021-12-01 한도숙 Cosmetic composition for improving skin moisturization containing spicule and method for preparing the same
JP2022547914A (en) * 2019-09-06 2022-11-16 ビーエヌカンパニー リミテッド Structure for promoting percutaneous absorption, method for producing said structure, and cosmetic composition containing said structure
JP7497901B2 (ja) 2019-09-06 2024-06-11 ビーエヌカンパニー リミテッド 経皮吸収を促進するための構造体、前記構造体の製造方法、及び前記構造体を含む化粧品組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100937389B1 (en) * 2009-01-23 2010-01-19 (주)스킨메디언스 Method for manufacturing cosmetics for improving the skin with cancellous bone grafts
KR20110051392A (en) * 2009-11-10 2011-05-18 코스맥스 주식회사 Cosmetic composition for exfoliating skin keratin
KR101728125B1 (en) * 2015-10-15 2017-04-19 (주)비엔 Method for manufacturing cosmetic composition containing porifera spicule

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100937389B1 (en) * 2009-01-23 2010-01-19 (주)스킨메디언스 Method for manufacturing cosmetics for improving the skin with cancellous bone grafts
KR20110051392A (en) * 2009-11-10 2011-05-18 코스맥스 주식회사 Cosmetic composition for exfoliating skin keratin
KR101147555B1 (en) * 2009-11-10 2012-05-21 코스맥스 주식회사 Cosmetic composition for exfoliating skin keratin
KR101728125B1 (en) * 2015-10-15 2017-04-19 (주)비엔 Method for manufacturing cosmetic composition containing porifera spicule

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200073327A (en) * 2018-12-13 2020-06-24 (주)파이온텍 Method for impregnating micropore of spicule with liposome
KR102272303B1 (en) * 2018-12-13 2021-07-05 (주)파이온텍 Method for impregnating micropore of spicule with liposome
JP2022547914A (en) * 2019-09-06 2022-11-16 ビーエヌカンパニー リミテッド Structure for promoting percutaneous absorption, method for producing said structure, and cosmetic composition containing said structure
EP4014951A4 (en) * 2019-09-06 2023-10-18 BN Co., Ltd. Structure for promoting transdermal absorption, preparation method therefor, and cosmetic composition comprising same
JP7497901B2 (ja) 2019-09-06 2024-06-11 ビーエヌカンパニー リミテッド 経皮吸収を促進するための構造体、前記構造体の製造方法、及び前記構造体を含む化粧品組成物
KR102297063B1 (en) 2020-10-20 2021-09-02 박경래 Cosmetic complex composition that helps skin keratin turnover cycle, skin trouble improvement and acne symptom relief, and its manufacturing method
KR102209847B1 (en) 2020-11-06 2021-03-24 주식회사 본에스티스 Functional cosmetic composition for skin moisturizing and soothing
KR102248733B1 (en) 2020-11-06 2021-05-07 주식회사 본에스티스 Functional cosmetic composition for improving skin wrinkles and elasticity
KR102333146B1 (en) 2021-06-14 2021-12-01 한도숙 Cosmetic composition for improving skin brightness containing spicule and method for preparing same
KR102333145B1 (en) 2021-06-14 2021-12-01 한도숙 Cosmetic composition for improving skin moisturization containing spicule and method for preparing the same

Similar Documents

Publication Publication Date Title
KR101897401B1 (en) Cosmetic composition for skin desquamation comprising powder of captured spicule using ultra high pressure as effective component
CN109152724B (en) Synergistic extract of palmaria palmiformis and jasmine, composition containing synergistic extract and application of synergistic extract
CN102178617A (en) Protein skin care products having function of skin repair and care
KR100443588B1 (en) Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect
CN108888634A (en) The preparation method and application of hair follicle stem cells extract freeze-drying powder
KR20160091300A (en) Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging
KR102037030B1 (en) Cosmetic composition for improving acne containing Phytosilica
KR101321346B1 (en) Cosmetic Composition comprising human stem cell conditioned media extracts in supercritical liposome as Active Ingredient
CN109381390A (en) A kind of sodium hyaluronate skin lightening Face-protecting mask and preparation method thereof
KR20140145278A (en) Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect
KR102130243B1 (en) A cosmetic composition for skin whitening, anti-wrinkle, anti-aging, and anti-oxidation containing glutathione, natural spicule powder, acetyl hexapeptide and broussonetia kazinoki extract
KR101489935B1 (en) Method for preparing mugwort extract and cosmetic composition comprising mugwort extract prepared therefrom
KR101798632B1 (en) Cosmetic composition containing stellera chamaejasme extract or fraction thereof and use thereof
CN105853341B (en) A kind of anti-aging skin care product and preparation method thereof containing epidermal stem cells secretin
CN107970194A (en) A kind of preserving moisture and protecting skin essence
CN105147575A (en) Hair restorer containing stem cells and preparation method thereof
KR101047873B1 (en) Cosmetic composition comprising human stem cell conditioned media extracts in supercritical liposome as active ingredient
KR20170141564A (en) Cosmetic composition containing propolis and extracts of opuntia humifusa
KR20170010499A (en) Cosmetic Compositions comprising Snail mucus fermentation filtrate for improving skin barrier function and having high skin absorption and Functional Cosmetic using this
KR102151501B1 (en) Composition for improving hair and head skin
KR101618726B1 (en) Method for making protein from Pollock skin
JP2010222273A (en) Hair-growing agent composition
KR101679391B1 (en) Composition for treating wound containing stellera chamaejasme extract or fraction thereof and method for treating wound in a subject
KR101550275B1 (en) Method for making glue from soft-shelled turtle and cosmetics containing the same
KR101574248B1 (en) Cosmetic composition comprising Reynoutria sachalinensis extracts for skin anti-wrinkle effect

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant